Business
Jaguar Health Subsidiary Napo Pharmaceuticals Wins 2019 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award
SAN FRANCISCO, CA / ACCESSWIRE / February 20, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), today announced that the nonprofit
About this update from Jaguar Health, Inc.
[{"type":"text","content":"SAN FRANCISCO, CA / ACCESSWIRE / February 20, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) (\"Jaguar\" or the \"Company\"), today announced that the nonprofit American Botanical Council (ABC) has given the 2019 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award to the Company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc. (\"Napo\") in recognition of Napo's ongoing commitment to the sustainable development and production of natural therapeutic preparations. Specifically, this award acknowledges the successful development and approval of crofelemer, which is derived from the medicinal Croton lechleri tree in the Amazon rainforest.Crofelemer, the active ingredient in Mytesi®, the Company's FDA-approved prescription drug product, is a naturally derived new molecular entity extracted and purified from the red bark sap of the Croton lechleri tree. The Croton lechleri sap, commonly known as sangre de drago (which translates to \"dragon's blood\" in Spanish), has a long history of medicinal use by indigenous peoples.\"We are very grateful to the American Botanical Council for this recognition,\" stated Steven King, PhD, Jaguar Health's executive vice president of sustainable supply, ethnobotanical research and intellectual property. \"We in turn would like to specifically acknowledge the intellectual contribution of local and indigenous peoples of the Northwest Amazon Basin for identifying the healing properties of traditional plant medicines. We would like to be sure that the international medical and patient community know that indigenous science and ethnomedical expertise continues to provide solutions to medical challenges for humans and animals.\"Lisa Conte, Jaguar Health's president and CEO, commented, \"We are delighted to receive this award that recognizes our focus on developing and commercializing novel, sustainably-derived therapeutics to enhance gastrointestinal health around the globe. We are also pleased to be among the distinguished group of past recipients that includes our esteemed partner, Indena.\"Indena S.p.A., one of the world's largest producers of clinically-tested botanical extracts for the food, dietary supplement, cosmetic, and pharmaceutical markets, received the ABC Tyler award in 2008.The ABC Tyler Award was created to honor one of the most respected U.S. scientists in late-20th centur...